Medical-device firm Boston Scientific said it will cut 2,300 jobs, or 8 percent of its workforce, as part of a bid to trim $500 million in annual operation costs. Much of the company’s financial problems occurred after its mid-2006 purchase of Guidant, which just recalled wires from its core defibrillator product line. (AP in USA Today)
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
How to create a healthy 'germier' homeUnder The Radar Exposure to a broad range of microbes can enhance our immune system, especially during childhood
-
George Floyd: Did Black Lives Matter fail?Feature The momentum for change fades as the Black Lives Matter Plaza is scrubbed clean
-
National debt: Why Congress no longer caresFeature Rising interest rates, tariffs and Trump's 'big, beautiful' bill could sent the national debt soaring
